ScholarIQanswers from OpenAlex & ORCID
Leo I. Gordon
ResearcherPublications, citations & collaboration network
Leo I. Gordon is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Leo I. Gordon have?
ScholarIQindexed works
Leo I. Gordon has 826 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Leo I. Gordon have?
ScholarIQcitation count
Leo I. Gordon has 43,240 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Leo I. Gordon?
ScholarIQh-index
Leo I. Gordon has an h-index of 91 in OpenAlex.
What is the i10-index of Leo I. Gordon?
ScholarIQi10-index
Leo I. Gordon has an i10-index of 322 in OpenAlex.
What is the ORCID of Leo I. Gordon?
ScholarIQorcid
The ORCID for Leo I. Gordon is on the source record.
What is the OpenAlex record for Leo I. Gordon?
ScholarIQopenalex
The OpenAlex for Leo I. Gordon is on the source record.
What are the most-cited papers on Leo I. Gordon?
ScholarIQmost cited works
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou, Laurie H. Sehn, Alfred Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby‐Thompson, Ann Vanderplas, Andrew D. Zelenetz, Gregory A. Abel, Maria Alma Rodriguez, Auayporn Nademanee, Mark Kaminski, Myron S. Czuczman, Michael Millenson, Joyce C. Niland, Randy D. Gascoyne, Joseph M. Connors, Jonathan W. Friedberg, Jane N. Winter
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand, Arnon Nagler, Edie Weller, Steven M. Devine, David Avigan, Yi‐Bin Chen, Mark Kaminski, H. Kent Holland, Jane N. Winter, James R. Mason, Joseph W. Fay, David A. Rizzieri, Chitra Hosing, Edward D. Ball, Joseph P. Uberti, Hillard M. Lazarus, Markus Y. Mapara, Stephanie A. Gregory, John M. Timmerman, David Andorsky, Reuven Or, Edmund K. Waller, Rinat Rotem‐Yehudar, Leo I. Gordon
Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma
Thomas E. Witzig, Christine A. White, Leo I. Gordon, Gregory A. Wiseman, Christos Emmanouilides, James L. Murray, John Lister, Pratik S. Multani
A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
Andrew M. Evens, Irene Helenowski, Erika Ramsdale, Chadi Nabhan, Reem Karmali, Britt Hanson, Benjamin M. Parsons, Scott E. Smith, Annette K. Larsen, June M. McKoy, Borko Jovanovic, Stephanie Gregory, Leo I. Gordon, Sonali M. Smith